Ultrasound II: Endoscopic Ultrasound and FibroScan
Ultrasonography
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This article evaluates a new medical imaging technique that monitors the effects of high-intensity focused ultrasound treatment on tissues. By analyzing natural physiological waves instead of applying external force, this method successfully detects and measures tissue changes in both laboratory models and human patients, offering a safer way to track cancer ablation.
05:56Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
Published on: January 9, 2019
08:08Evaluating Targeting Accuracy in the Focal Plane for an Ultrasound-guided High-intensity Focused Ultrasound Phased-array System
Published on: March 6, 2019
Area of Science:
Background:
No prior work had resolved the challenge of reliable, real-time monitoring for high-intensity focused ultrasound procedures. Current clinical standards rely heavily on detecting bubble formation, which provides limited information about the actual tissue state. It was already known that thermal ablation induces significant changes in tissue stiffness. However, traditional elastography methods require an external mechanical push, which proves difficult to implement in deep-seated organs. This gap motivated the development of alternative approaches that avoid invasive physical perturbations. Researchers have long sought methods to visualize ablation zones without compromising the safety of the surrounding anatomy. Passive elastography has emerged as a promising candidate by utilizing existing physiological wave fields. That uncertainty drove the investigation into whether this non-invasive technique could effectively map elasticity changes during clinical interventions.
Purpose Of The Study:
The aim of this study is to evaluate the capacity of passive elastography to monitor high-intensity focused ultrasound lesions. Researchers sought to address the lack of reliable, non-invasive monitoring techniques currently available for clinical ablation procedures. The team aimed to determine if physiological wave fields could serve as a substitute for external mechanical perturbations. They investigated whether this method could function independently of the chaotic bubble formation that often limits standard ultrasound monitoring. The study intended to validate the technique across a progression of test environments, including phantoms, animal models, and human patients. By testing this approach, the authors hoped to overcome the technical barriers that restrict the use of focused ultrasound in deep-seated organs. They specifically focused on the ability to detect and delineate lesions with high precision. This work was motivated by the need to improve the safety and efficacy of ultrasound-based cancer therapies.
Main Methods:
The review approach involved adapting existing image processing algorithms to work with standard clinical ultrasound hardware. Investigators first established baseline accuracy using controlled phantom environments to verify elasticity measurements. They then integrated the software into the Focal One platform to test performance under laboratory conditions. The team evaluated the contrast-to-noise ratio to quantify the clarity of lesion detection. Following successful bench testing, they transitioned to porcine liver models to assess performance in complex biological tissues. The researchers captured physiological wave fields to map stiffness without applying any external force. Finally, they conducted a pilot study involving four human subjects to observe real-world clinical utility. This systematic validation confirmed the feasibility of the approach across multiple experimental scales.
Main Results:
Key findings from the literature demonstrate that the technique achieves a contrast-to-noise ratio of 9.2 decibels during in vitro lesion detection. The method successfully delineated lesions of varying sizes within porcine liver tissue using only natural wave fields. In human prostate cancer patients, the researchers observed a significant average elasticity variation of 33.0 ± 16.0 percent after treatment. These results confirm that the approach remains independent of bubble-related artifacts that typically plague conventional monitoring. The data show consistent performance across both controlled laboratory settings and complex clinical environments. The ability to detect these changes without external pressure represents a major advancement in monitoring capability. The findings provide strong evidence that the system can track ablation zones effectively. This performance profile supports the utility of the method for real-time clinical decision-making.
Conclusions:
The authors propose that passive elastography serves as a viable tool for tracking thermal ablation progress. This approach demonstrates independence from bubble-related artifacts that often obscure standard ultrasound monitoring. Evidence from porcine models confirms the ability to delineate lesions of varying dimensions accurately. Clinical data from prostate cancer patients reveal significant shifts in tissue elasticity following the application of focused energy. These findings suggest that the technique could facilitate wider adoption of ultrasound-based cancer therapies. The researchers emphasize that the method successfully operates using standard clinical imaging hardware. Future clinical integration may benefit from the observed thirty-three percent average variation in tissue stiffness. This synthesis implies that non-invasive monitoring could enhance the precision and safety of oncological interventions.
The researchers propose that the mechanism relies on processing physiological wave fields to estimate tissue elasticity. This approach avoids the need for external mechanical perturbations, allowing for the detection of lesions independent of gas bubbles that typically interfere with standard ultrasound monitoring during thermal ablation.
The team utilized the Focal One clinical system to perform the imaging. This platform allowed for the adaptation of passive elastography to process standard B-mode images, facilitating both in vitro testing and subsequent human patient evaluations.
The authors note that the technique was first validated in calibrated phantoms. This step was necessary to confirm that the system could faithfully assess elasticity before moving to complex biological models or human subjects.
The researchers used B-mode images acquired from clinical systems. This data type is essential because it allows the algorithm to extract elasticity information from existing physiological wave fields without requiring additional hardware or invasive procedures.
The study measured a contrast-to-noise ratio of 9.2 decibels in vitro. Additionally, the researchers observed an average elasticity variation of 33.0 ± 16.0 percent in prostate cancer patients following the high-intensity focused ultrasound procedure.
The authors suggest that their findings could help spread the clinical use of high-intensity focused ultrasound. By providing a reliable monitoring method, the technique may overcome current limitations that restrict the application of this treatment modality for various pathologies.